UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055118
Receipt number R000062959
Scientific Title A Prospective Observational Study on the Diagnostic Accuracy of the Acoustic Roughness Index (ARI) for Perceptual Roughness
Date of disclosure of the study information 2024/08/15
Last modified on 2025/06/17 09:10:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective study on diagnosis of hoarseness by acoustic measurement

Acronym

Prospective study on diagnosis of hoarseness by acoustic measurement

Scientific Title

A Prospective Observational Study on the Diagnostic Accuracy of the Acoustic Roughness Index (ARI) for Perceptual Roughness

Scientific Title:Acronym

A Prospective Observational Study on the Diagnostic Accuracy of ARI for Perceptual Roughness

Region

Japan


Condition

Condition

Patients with voice disorders presenting with hoarseness

Classification by specialty

Oto-rhino-laryngology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Hoarse voices can be classified into rough or breathy categories based on auditory-perceptual judgments. It is known that the primary cause of breathy voices is simply the insufficiency of vocal fold closure during vocalization. However, the mechanism causing rough voices is not defined by a single factor, as is the case with breathy voices. Rough voices are related to a combination of factors such as the irregular vibration patterns of the vocal cords or their surroundings, as well as the pitch of the voice. Therefore, there is no single characteristic of the voice waveform of rough voices, and no acoustic measures have been able to objectively evaluate them.

The ARI developed by our group incorporates parameters for subharmonics, which are not included in conventional indices, into a regression equation based on an existing database, dramatically improving diagnostic accuracy. This study aims to evaluate the generalizability of its high diagnostic accuracy.

Basic objectives2

Others

Basic objectives -Others

Diagnostic accuracy

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

or all samples registered in this study, an auditory-perceptual evaluation will be conducted to assess the degree of rough hoarseness on a scale of 0 to 3 (R score). Samples with an average R score of 0.5 or higher from three or more evaluators will be classified as having rough hoarseness, while those with lower scores will be classified as not having rough hoarseness. ROC analysis will be performed using ARI, and the diagnostic accuracy will be evaluated based on the AUC value from the ROC analysis.


Diagnostic Accuracy of ARI for Roughness
For all samples registered in this study, an auditory-perceptual judgment will be conducted to assess the degree of roughness on a scale of 0 to 3 (R score). Samples with an average R score of 0.5 or higher from three or more evaluators will be classified as having roughness, while those with lower scores will be classified as not having roughness. ROC analysis will be performed using ARI, and the diagnostic accuracy will be evaluated based on the AUC value from the ROC analysis.

Key secondary outcomes

Calculation of Minimal Important Difference (MID) and Minimal Detectable Change (MDC) for AVQI, ABI and ARI


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patient must have hoarseness with an auditory-perceptual judgment of G1 or higher in conversational speech or sustained vowel utterance at the time of examination.
The patient must be at least 18 years of age at the time of consent.

Key exclusion criteria

Those whose first language is not Japanese.
Those who are unable to move to the recording room.
Other patients who are deemed inappropriate to participate in the study by the physician in charge.

Target sample size

400


Research contact person

Name of lead principal investigator

1st name Kiyohito
Middle name
Last name Hosokawa

Organization

The University of Osaka Graduate School of Medicine

Division name

Department of Otorhinolaryngology - Head and Neck Surgery

Zip code

565-0871

Address

2-2, Yamadaoka, Suita-city, Osaka, Japan.

TEL

06-6879-3951

Email

khosokawa@ent.med.osaka-u.ac.jp


Public contact

Name of contact person

1st name Kiyohito
Middle name
Last name Hosokawa

Organization

The University of Osaka Graduate School of Medicine

Division name

Department of Otorhinolaryngology - Head and Neck Surgery

Zip code

565-0871

Address

2-2, Yamadaoka, Suita-city, Osaka, Japan.

TEL

06-6879-3951

Homepage URL


Email

khosokawa@ent.med.osaka-u.ac.jp


Sponsor or person

Institute

Osaka University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

No

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The University of Osaka Hospital

Address

2-15, Yamadaoka, Suita-city, Osaka, japan

Tel

06-6879-3951

Email

khosokawa@ent.me.osaka-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 08 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2024 Year 07 Month 30 Day

Date of IRB

2024 Year 06 Month 27 Day

Anticipated trial start date

2024 Year 08 Month 01 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Study design: Cohort study
Method of recruitment: All patients who visited our facility between August 2024 and March 2027 and met the selection criteria.


Management information

Registered date

2024 Year 07 Month 30 Day

Last modified on

2025 Year 06 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062959